Bullous Delayed Pressure Urticaria Responding to Omalizumab

Acta Derm Venereol. 2016 Mar;96(3):416-7. doi: 10.2340/00015555-2224.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blister / drug therapy*
  • Blister / etiology
  • Blister / immunology
  • Blister / pathology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Omalizumab / therapeutic use*
  • Pressure*
  • Remission Induction
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Treatment Outcome
  • Urticaria / drug therapy*
  • Urticaria / etiology
  • Urticaria / immunology
  • Urticaria / pathology

Substances

  • Immunologic Factors
  • Omalizumab